Outcomes After Dorsal Wrist Ganglia Excision With or Without PIN
Launched by KENNETH TAYLOR, M.D. · Jun 17, 2021
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The primary endpoint will be outcomes on subject surveys and questionnaires. Data will be collected pre- and post-operatively at 2 weeks, 12 weeks, 6 months, and one year. Four questionnaires will be used, including the Visual Analog Pain Score (VAS), Disabilities of the Arm, Shoulder, and Hand (QuickDASH) questionnaire, as well as the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PI), and the PROMIS Pain Behavior (PB) questionnaires.
Secondary outcomes include physical examination consisting of pre- and post-operative pinch and grip strength testing,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Greater than or equal to 18 years of age
- • Gender: male/female (non-pregnant)
- • Diagnosis of symptomatic (pain and limited ability to perform activities of daily living) dorsal wrist ganglion cyst
- • Subjects who have chosen surgical management for their ganglion cyst diagnosis
- • Fluent in written and spoken English
- • Subject is able to provide voluntary, written informed consent
- • Subject, in the opinion of the clinical investigator, is able to understand the clinical investigation and is willing to perform all study procedures and follow-up visits
- • Non-Prisoners
- Exclusion Criteria:
- • Less than 18 years of age
- • Non-elective surgery for this diagnosis
- • Chronic wrist instability of the operative extremity
- • Comorbid neurologic maladies of the operative extremity
- • Prior wrist surgery on either extremity
- • Non-English speaking
- • Prisoners
- • Pregnancy
- • Cognitive Impairment
About Kenneth Taylor, M.D.
Dr. Kenneth Taylor, M.D. is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient outcomes. With extensive experience in clinical medicine and a commitment to innovative therapeutic solutions, Dr. Taylor leads initiatives that focus on rigorous study design, ethical standards, and regulatory compliance. His collaborative approach fosters partnerships with research institutions and healthcare professionals, ensuring that trials are conducted with the highest level of integrity and scientific rigor. Through his leadership, Dr. Taylor aims to contribute to the development of safe and effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hershey, Pennsylvania, United States
Camp Hill, Pennsylvania, United States
Patients applied
Trial Officials
Kenneth Taylor, MD
Principal Investigator
Penn State Health Milton S Hershey Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials